Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#2930 Treatment of the Pinealoma: Experience from a Rare Case
Introduction: Pinealoma is an extremely rare type of neuroendocrine tumor without evidence-based systemic therapy.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Zhang Y, Liu M, Chen L, Guo Y, Chen M,
Keywords: pinealoma, octreotide, interferon.,
#2290 PRRT in Hindgut and Cancer of Unknown Primary NEN
Introduction: There are limited data regarding PRRT in hindgut and CUP (cancer of unknown primary).
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Ćwikla J
Authors: Kolasińska-Ćwikła A, Lewczuk-Myślińska A, Cichocki A, Roszkowska-Purska K, Dobkowski P,
Introduction: From March 2016, patients with M+ NET are treated with PRRT at the Netherlands Cancer Institute.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Huizing D, Versleijen M, Geluk - Jonker M, Hendrikx J, De Wit - Van Der Veen L,
Keywords: PRRT, adverse events, clinical symptoms,
#1935 Prevalence of Pancreatic Neuroendocrine Neoplasms with Serotonin Secretion
Introduction: Pancreatic neuroendocrine neoplasms (pNENs) are rare neoplasms and represent 1-2% of all pancreatic neoplasms. These tumors can secrete a variety of hormonally active substances producing distinct clinical symptoms, or can be clinically non-functioning. Pancreatic NENs that secrete serotonin are extremely rare, but their prevalence has not been explored adequately.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Tsoukalas N
Authors: Tsoukalas N, Alexandraki K, Mavroeidi V, Chatzellis E, Tsoli M,
Keywords: serotonin-producing pNEN, 5-HIAA, prognosis,
#1387 FOLFOX in Neuroendocrine Tumors
Introduction: Favorable toxicity profile and significant antitumor activity of FU-oxaliplatin in several malignancies led us to evaluate FOLFOX in advanced neuroendocrine carcinomas (NETs).
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Faure M
Authors: Faure M, Raoul J, Autret A, Mineur L, Boustany R,
Keywords: Neuroendocrine tumors, folfox, clinical improvement, break in treatment, PFS, OS,